OSTX

Profile

Full Name

OS Therapies Incorporated

Ticker Symbol

OSTX

Exchange

NYSE

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 1, 2024

Indexes

Not included

Website

http://ostherapies.com

Employees

4

Key Details

Price

$1.57(+9.03%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.88(-128.99% YoY)

PE ratio

-

Next earnings date

May 20, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.57
OSTX price is $1.57

30-Day Relative Volume

2.03
OSTX 30-day relative volume is 2.03

Price Performance

Price Today change

+9.03%
OSTX price is up +9.03% today

Price YTD change

-63.32%
OSTX price is down -63.32% since January 1st

Price 1-year change

-
OSTX price 1-year change is unknown

Price 3-year change

-
OSTX price 3-year change is unknown

Price Range

Price All-time high

$7.00
OSTX price is currently -77.57% below its historical high of $7.00

Price 3-year low

$1.12
OSTX price is currently +40.18% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$34.01M
OSTX market capitalization is $34.01 million

Market cap 3-year change

-
OSTX market capitalization 3-year change is unknown

Market cap All-time high

$109.59M
OSTX market capitalization is currently -68.96% below its historical high of $109.59 million

Market cap sector rank

33.06%
OSTX market capitalization is higher than 33.06% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+5.18%
OSTX shares outstanding is up +5.18% year-on-year

Shares Outstanding 3-Year Change

-
OSTX shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.90
OSTX beta is 0.90

200-day SMA

$2.78
OSTX price is currently -43.55% below its 200-day simple moving average

50-day SMA

$1.64
OSTX price is currently -4.17% below its 50-day simple moving average

RSI

51.44
OSTX 14-day relative strength index is 51.44

Volume

2.03
OSTX 30-day relative volume is 2.03

ATR

$0.17
OSTX average true range is $0.17

10-day Historical Volatility

145.19%
OSTX 10-day historical volatility is 145.19%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
OSTX annual revenue value is unknown

Revenue Analysts estimate

$27.50M
OSTX annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
OSTX annual revenue 1-year change is unknown

Revenue Sector rank

-
OSTX annual revenue is unknown

EPS

EPS

-$0.88
OSTX annual earnings per share is -$0.88

EPS Analysts estimate

$0.68
OSTX annual earnings per share is currently -230.04% lower than the consensus analysts' forecast

EPS 1-year change

-128.99%
OSTX annual earnings per share is down -128.99% year-on-year

EPS Sector rank

59.57%
OSTX annual earnings per share is higher than 59.57% of companies in Healthcare sector

Profit

Gross profit

-
OSTX annual gross profit value is unknown

Gross margin

-
OSTX annual gross profit margin value is unknown

Operating profit

-$6.81M
OSTX annual operating income is -$6.81 million

Operating margin

-
OSTX annual operating profit margin value is unknown

Net income

-$8.88M
OSTX annual net profit is -$8.88 million

Net margin

-
OSTX annual net profit margin value is unknown

Expenses

Total expenses

$6.81M
OSTX annual total expenses is $6.81 million

Operating expenses

$6.81M
OSTX annual total operating expenses is $6.81 million

Cost of goods sold

-
OSTX annual cost of goods sold value is unknown

Selling, general & administrative expenses

$3.97M
OSTX annual SGA is $3.97 million

Depreciation and amortization

$2800.00
OSTX annual depreciation & amortization is $2800.00

Interest expense

$2.05M
OSTX annual interest expense is $2.05 million

Income tax

-
OSTX annual income tax value is unknown

EBIT & EBITDA

EBIT

-$6.83M
OSTX annual earnings before interest & taxes is -$6.83 million

EBITDA

-$6.83M
OSTX annual EBITDA is -$6.83 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$5.54M
OSTX annual total assets is $5.54 million

Non current assets

$5300.00
OSTX annual long term assets is $5300.00

Current assets

$5.53M
OSTX annual total current assets is $5.53 million

Cash and cash equivalents

$5.53M
OSTX annual cash & cash equivalents is $5.53 million

Accounts receivable

-
OSTX annual accounts receivable value is unknown

Inventory

-
OSTX annual inventory value is unknown

Liabilities

Total liabilities

$4.73M
OSTX annual total liabilities is $4.73 million

Long term liabilities

$100.00K
OSTX annual total long term liabilities is $100.00 thousand

Current liabilities

$4.63M
OSTX annual total current liabilities is $4.63 million

Accounts payable

$1.66M
OSTX annual accounts payable is $1.66 million

Debt

Total debt

$0.00
OSTX annual total debt is $0.00

Total debt 1-year change

-100%
OSTX annual total debt is down -100% year-on-year

Long term debt

-
OSTX annual long term debt value is unknown

Short term debt

-
OSTX annual short term debt value is unknown

Equity & Capital

Shareholders equity

$811.50K
OSTX annual stockholders equity is $811.50 thousand

Book value

-$5.24M
OSTX annual book value is -$5.24 million

Retained earnings

-$40.40M
OSTX annual retained earnings is -$40.40 million

Working capital

$906.20K
OSTX annual working capital is $906.20 thousand

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$7.28M
OSTX annual cash flow from operations is -$7.28 million

Cash from operations 1-year change

-142.18%
OSTX annual cash flow from operations is down -142.18% year-on-year

Cash from investing

$0.00
OSTX annual cash flow from investing activities is $0.00

Cash from investing 1-year change

-100%
OSTX annual cash flow from investing activities is down -100% year-on-year

Cash from financing

$12.78M
OSTX annual cash flow from financing activities is $12.78 million

Cash from financing 1-year change

+344.67%
OSTX annual cash flow from financing activities is up +344.67% year-on-year

CAPEX

CAPEX

-
OSTX annual capital expenditures value is unknown

CAPEX 1-year change

-
OSTX annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$7.28M
OSTX annual free cash flow is -$7.28 million

Free cash flow 1-year change

-142.18%
OSTX annual free cash flow is down -142.18% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
OSTX annual gross profit margin value is unknown

Operating margin

-
OSTX annual operating profit margin value is unknown

Net margin

-
OSTX annual net profit margin value is unknown

ROA & ROE

ROA

-160.38%
OSTX annual return on assets is -160.38%

ROE

-1094.63%
OSTX annual return on equity is -1094.63%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
OSTX price to earnings ratio value is unknown

PE ratio Sector rank

-
OSTX price to earnings ratio is unknown

PB Ratio

PB ratio

-6.49
OSTX price to book ratio is -6.49

PB ratio Sector rank

3.29%
OSTX price to book ratio is higher than 3.29% of companies in Healthcare sector

PS Ratio

PS ratio

-
OSTX price to sales ratio value is unknown

PS ratio Sector rank

-
OSTX price to sales ratio is unknown

Enterprise value

Enterprise value

$28.48M
OSTX enterprise value is $28.48 million

Enterprise value Sector rank

34.9%
OSTX enterprise value is higher than 34.9% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-4.17
OSTX EV/EBITDA is -4.17

EV/EBITDA Sector rank

20.45%
OSTX EV/EBITDA is higher than 20.45% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.20
OSTX annual current ratio is 1.20

Quick ratio

-
OSTX annual quick ratio value is unknown

Leverage

Debt to equity

0.00
OSTX annual debt to equity ratio is 0.00

Interest coverage ratio

-3.33
OSTX annual interest coverage ratio is -3.33

Risk & Stability

Piotroski F-Score

-
OSTX piotroski f-score value is unknown

Altman Z-Score

-
OSTX altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Apr 7, 25 D. Boral Capital
Buy
Apr 2, 25 Lake Street
Buy
Mar 31, 25 D. Boral Capital
Buy
Feb 24, 25 D. Boral Capital
Buy
Feb 20, 25 D. Boral Capital
Buy
Feb 4, 25 D. Boral Capital
Buy
Jan 30, 25 D. Boral Capital
Buy
Jan 16, 25 Maxim Group
Buy
Jan 15, 25 D. Boral Capital
Buy
Nov 26, 24 Maxim Group
Buy

Institutional Ownership

Similar stocks

FEMY logo
Femasys (FEMY)
Spectral AI (MDAI)
LSB logo
LakeShore Biopharma Co Ltd (LSB)
CASI logo
CASI Pharmaceuticals (CASI)
ESLA logo
Estrella Immunopharma (ESLA)
INKT logo
MiNK Therapeutics (INKT)
Cadrenal Therapeutics (CVKD)
PIII logo
P3 Health Partners (PIII)
BNR logo
Burning Rock Biotech Limited (BNR)
  • What is the ticker symbol for OS Therapies Incorporated?
  • Does OS Therapies Incorporated pay dividends?
  • What sector is OS Therapies Incorporated in?
  • What industry is OS Therapies Incorporated in?
  • What country is OS Therapies Incorporated based in?
  • When did OS Therapies Incorporated go public?
  • Is OS Therapies Incorporated in the S&P 500?
  • Is OS Therapies Incorporated in the NASDAQ 100?
  • Is OS Therapies Incorporated in the Dow Jones?
  • When was OS Therapies Incorporated's last earnings report?
  • When does OS Therapies Incorporated report earnings?
  • Should I buy OS Therapies Incorporated stock now?

What is the ticker symbol for OS Therapies Incorporated?

The ticker symbol for OS Therapies Incorporated is NYSE:OSTX

Does OS Therapies Incorporated pay dividends?

No, OS Therapies Incorporated does not pay dividends

What sector is OS Therapies Incorporated in?

OS Therapies Incorporated is in the Healthcare sector

What industry is OS Therapies Incorporated in?

OS Therapies Incorporated is in the Biotechnology industry

What country is OS Therapies Incorporated based in?

OS Therapies Incorporated is headquartered in United States

When did OS Therapies Incorporated go public?

OS Therapies Incorporated's initial public offering (IPO) was on August 1, 2024

Is OS Therapies Incorporated in the S&P 500?

No, OS Therapies Incorporated is not included in the S&P 500 index

Is OS Therapies Incorporated in the NASDAQ 100?

No, OS Therapies Incorporated is not included in the NASDAQ 100 index

Is OS Therapies Incorporated in the Dow Jones?

No, OS Therapies Incorporated is not included in the Dow Jones index

When was OS Therapies Incorporated's last earnings report?

OS Therapies Incorporated's most recent earnings report was on Mar 31, 2025

When does OS Therapies Incorporated report earnings?

The next expected earnings date for OS Therapies Incorporated is May 20, 2025

Should I buy OS Therapies Incorporated stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page